NRX Pharmaceuticals Inc (NRXP) stock news · rev $1.2M
NRX Pharmaceuticals Inc (NRXP) is a biotechnology company listed on US.
This NRXP news page leads with what NRX Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for NRXP yet. We will not pad this page with generic market recap.
Latest reported NRXP revenue for 2025-12-31 was $1.2M. Net income was -$28.6M. NRXP currently screens at market cap $169.9M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NRXP stock page; for the tape open the quote page.
Not investment advice.